| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 04/03/2003 | US20030064466 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of tumors and cell proliferative disorders |
| 04/03/2003 | US20030064465 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064464 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064463 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064462 Nucleotide sequences coding polypeptide for use in the treatment of tumor and cell proliferative disorders |
| 04/03/2003 | US20030064461 Nucleotide sequences coding polypeptide for use in the treatment of tumor and cell proliferative disorders |
| 04/03/2003 | US20030064460 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064459 Nucleotide sequences coding polypeptide for use in the treatment of tumor and cell proliferative disorders |
| 04/03/2003 | US20030064458 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064457 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064456 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064455 Nucleotide sequences coding polypeptide for use in the treatment of tumor and cell proliferative disorders |
| 04/03/2003 | US20030064451 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064450 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064449 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064448 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064447 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064446 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064445 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064444 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064443 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064442 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064410 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 04/03/2003 | US20030064391 Preparation of sequences on substrate; obtain substrate, deposit on plate surface, incubate with activator, remove protective groups, recover biopolymer |
| 04/03/2003 | US20030064359 Preparation of highly-purified plasma membranes |
| 04/03/2003 | US20030063112 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | CA2461898A1 Biological control of nanoparticles |
| 04/03/2003 | CA2460953A1 Proteins associated with cell growth, differentiation, and death |
| 04/03/2003 | CA2453985A1 Receptors and membrane-associated proteins |
| 04/02/2003 | EP1297175A2 Methods and compounds for modulating nuclear receptor coactivator binding |
| 04/02/2003 | EP1297116A2 Method for isolating and purifying a protein and resulting protein |
| 04/02/2003 | EP1297016A2 Use of inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumour formation and/or vascular leakage |
| 04/02/2003 | EP1297014A2 Transporters and ion channels |
| 04/02/2003 | EP1296948A2 Novel gamma crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same. |
| 04/02/2003 | EP1296947A1 $g(A) CRYSTALLINE FORM OF PERINDOPRIL TERT-BUTYLAMINE SALT |
| 04/02/2003 | EP1296756A2 Method and device for investigating the molecular interaction of soluble or suspendable active substances with solid-phase bonded peptidic or peptoid target molecules by means of capillary plates having a large inner surface |
| 04/02/2003 | EP0762897B1 Method of preventing aggregation of proteins/peptides upon rehydration or thawing |
| 04/02/2003 | EP0673392B1 Method of preferential labelling of phycobiliprotein with amine-reactive dye for use in a multiple color assay |
| 04/02/2003 | CN1407992A Process for producing functional silk fibroin and utilization of the same |
| 04/01/2003 | US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis |
| 04/01/2003 | US6541620 Antagonist for tumor necrosis factor; antiinflammatory agents; rheumatic diseases |
| 04/01/2003 | US6541453 Peptide derivatives |
| 04/01/2003 | US6541002 Rendering a polypeptide capable of binding with virion by altering the polypeptide such that the altered polypeptide comprises a Vpr-binding region having specific amino acid sequence |
| 04/01/2003 | US6540961 Flow cell includes inlet and outlet chambers connected to a flow cell chamber; an array containing electrodes is within the flow cell chamber; inlet and outlet chambers have constant cross-sectional flow areas |
| 04/01/2003 | CA2102129C Growth hormone antagonists |
| 04/01/2003 | CA1341426C Process for the manufacture of thrombin inhibitors |
| 03/27/2003 | WO2003025565A2 Preparation of highly-purified plasma membranes |
| 03/27/2003 | WO2003025156A2 Methods and apparatuses for purification |
| 03/27/2003 | WO2003025004A2 Purified bacterial polypeptides involved in nucleic acid processing |
| 03/27/2003 | WO2002081078A3 Solid phase synthesis supports and methods |
| 03/27/2003 | WO2002068927A3 Using viruses to detect or purify proteins |
| 03/27/2003 | WO2002056829A3 Methods for preparing purified daptomycin |
| 03/27/2003 | WO2002055992A3 Intrinsically fluorescent, self-multimerizing mhc fusion proteins and complexes thereof |
| 03/27/2003 | WO2002040508A3 Lactam dipeptide and its use in inhibiting beta-amyloid peptide release |
| 03/27/2003 | WO2002022684A3 Transporters and ion channels |
| 03/27/2003 | WO2002012340A3 Transporters and ion channels |
| 03/27/2003 | WO2001070685A3 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
| 03/27/2003 | US20030060663 Novel therapeutic agents for macromolecular structures |
| 03/27/2003 | US20030060616 Type II IL-1 receptors |
| 03/27/2003 | US20030060602 Polypeptide for use in human therapeutics and diagnostics |
| 03/27/2003 | US20030060601 Polypeptide for use in human therapeutics and diagnostics |
| 03/27/2003 | US20030060600 Polypeptide for use in human therapeutics and diagnostics |
| 03/27/2003 | US20030060412 Dissolving in aqueous base or in aqueous acid, neutralized to a pH at which substantially no amino acid racemization; stimulate insulin secretion for the treatment of diabetes, obesity |
| 03/27/2003 | US20030059952 Method and product for the sequence determination of peptides using a mass spectrometer |
| 03/27/2003 | US20030059929 Apparatus for use in the preparation or analysis of biopolymers |
| 03/27/2003 | US20030059910 Oil bodies and associated proteins as affinity matrices |
| 03/27/2003 | US20030059909 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative disorders |
| 03/27/2003 | US20030059886 Nucleotide sequences coding polypeptide for use in the treatment diagnosis and prevention of tumor and cell proliferative disorders |
| 03/27/2003 | US20030059885 Nucleotide sequences coding polypeptide for use in the treatment diagnosis and prevention of tumor and cell proliferative disorders |
| 03/27/2003 | US20030059883 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/27/2003 | US20030059882 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/27/2003 | US20030059880 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/27/2003 | US20030059879 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/27/2003 | US20030059859 Vertebrate protein for use in human therapeutic and diagnostics |
| 03/27/2003 | US20030059849 Crystallization of proteins; obtain protein sample, mix with crystallization reagents, crystallize, x-ray, evaluate and analyze diffraction pattern images |
| 03/27/2003 | US20030059847 Generation of flurogenic substrates; couple fluorogenic compounds to solid support, join substrate to solid support, expose to ammonia and release flurogenic substrate from support |
| 03/27/2003 | US20030059826 Soluble combinatorial library for use as tool in drug discovery |
| 03/27/2003 | US20030059785 Detection of markers in nascent proteins |
| 03/27/2003 | US20030059765 Compositions and methods for providing a protein to a virion |
| 03/27/2003 | US20030059422 Tuftsin metallopeptide analogs and uses thereof |
| 03/27/2003 | US20030058239 Three dimensional protein mapping |
| 03/27/2003 | CA2460819A1 Methods and apparatuses for purification |
| 03/27/2003 | CA2460568A1 Preparation of highly-purified plasma membranes |
| 03/26/2003 | EP1295952A2 Methods for screening for transdominant effector peptides and RNA molecules |
| 03/26/2003 | EP1295894A1 Method for an in vitro sequence specific biotinylation of polypeptides |
| 03/26/2003 | EP1295123A1 Selective labeling and isolation of phosphopeptides and applications to proteome analysis |
| 03/26/2003 | EP1294886A2 THREE-DIMENSIONAL MODEL OF A Fc REGION OF AN IGE ANTIBODY AND USES THEREOF |
| 03/26/2003 | EP1294884A2 Secretion and trafficking molecules |
| 03/26/2003 | EP1294883A2 Human extracellular matrix (ecm)-related tumor marker |
| 03/26/2003 | EP1294750A2 Acid-modified arabinogalactan protein composition |
| 03/26/2003 | EP1294747A2 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 03/26/2003 | EP1294746A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 03/26/2003 | EP1294743A2 Method of obtaining peptides with tissue-specific activity and pharmaceutical compositions on their basis |
| 03/26/2003 | EP1294689A1 Novel $g(b crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same |
| 03/26/2003 | EP1294472A1 Electrophoresis separation and treatment of samples |
| 03/26/2003 | EP1180111A4 Method and apparatus for compound library preparation using optical modulator |
| 03/26/2003 | EP0986585B1 Use of ylides of phosphorus as slightly nuceophilic strong bases |
| 03/26/2003 | EP0828753B1 Al/Fe-TREATMENT OF A PROTEIN SOLUTION, FOLLOWED BY MEMBRANE CONCENTRATION |
| 03/26/2003 | CN1406276A Sericin-containing material, Process for producing the same and method of using the same |
| 03/26/2003 | CN1406246A Method of producing human albumin involving heating step |